Group 1 - The stock of Wealth Trend (688318) has a comprehensive score of 55.72, indicating a strong performance [1] - The main cost analysis shows the following prices: current main cost at 115.60 CNY, 5-day main cost at 108.76 CNY, 20-day main cost at 107.99 CNY, and 60-day main cost at 100.80 CNY [1] - In the past year, the stock has hit the upper limit of trading three times and has not hit the lower limit [1] Group 2 - Northbound capital data indicates a holding of 1.0691 million shares, accounting for 0.58% of the circulating shares, with a net purchase of 168,800 shares yesterday [1] - The short-term pressure level is at 108.47 CNY, while the short-term support level is at 102.95 CNY; the stock price has broken through the short-term pressure level, suggesting potential short-term strength [2] - The net inflow of main funds on July 11, 2025, was 167.79 million CNY, accounting for 11% of the total transaction amount [2]

Group 1 - The stock of Aerospace Technology (688239) has a comprehensive score of 58.37, indicating a strong performance [1] - The main cost analysis shows the following prices: current main cost at 33.91 CNY, 5-day main cost at 33.69 CNY, 20-day main cost at 33.01 CNY, and 60-day main cost at 31.83 CNY [1] - In the past year, the stock has not experienced any limit-up or limit-down events [1] Group 2 - The short-term pressure level is at 34.28 CNY, while the short-term support level is at 33.11 CNY [2] - The mid-term pressure level is at 34.98 CNY, and the mid-term support level is at 30.77 CNY [2] - The current short-term and mid-term trends are unclear, awaiting direction from main funds [2][3] Group 3 - On July 11, 2025, the net outflow of main funds was 744.42 million CNY, accounting for -5% of the total transaction amount [2] - The breakdown of fund flows includes a net outflow of 453.63 million CNY from large orders and 290.79 million CNY from super large orders, while retail investors saw a net inflow of 89.21 million CNY [2][3] - The stock is associated with industries such as aerospace (0.57%), commercial aerospace (0.29%), large aircraft (0.40%), and western development (0.35%) [2] Group 4 - The latest financial data shows earnings per share at 0.29 CNY, operating profit at 0.51 billion CNY, and a net profit of approximately 46.37 million CNY [2][3] - The sales gross margin is reported at 26.229% [2][3]

Group 1 - The stock of Transsion Holdings (688036) has a comprehensive score of 48.35, indicating a weak performance [1] - The main cost analysis shows that the current main cost is 75.44 yuan, with a 5-day cost of 76.05 yuan and a 20-day cost of 77.28 yuan [1] - There have been no instances of the stock hitting the upper or lower limits in the past year [1] Group 2 - The short-term pressure level is at 77.36 yuan, while the short-term support level is at 74.63 yuan [2] - The K-line pattern indicates a long upper shadow, suggesting heavy pressure at the upper levels and a blocked upward trend [2] - On July 11, 2025, the net inflow of main funds was 15.61 thousand yuan, with a significant net inflow of 993.65 thousand yuan from large orders [2]

Core Viewpoint - The stock of XD Yingtong (688080) is currently showing a weak performance with a comprehensive score of 47.54, indicating uncertainty in both short-term and mid-term trends, awaiting direction from major funds [1][2]. Price and Cost Analysis - The current main cost is 46.53 CNY, with a 5-day main cost of 47.25 CNY, a 20-day main cost of 47.53 CNY, and a 60-day main cost of 45.46 CNY [1]. - The stock has not experienced any limit-up or limit-down events in the past year [1]. Technical Analysis - Short-term pressure level is at 48.39 CNY, while short-term support level is at 46.32 CNY [2]. - Mid-term pressure level is at 50.69 CNY, and mid-term support level is at 45.76 CNY [2]. - No special K-line patterns are observed at this time [2]. Fund Flow Data - On July 11, 2025, the net outflow of major funds was 357.65 thousand CNY, accounting for 8% of the total transaction volume [2]. - The net outflow from super large orders was 152.55 thousand CNY, and from large orders was 205.10 thousand CNY, while retail investors saw a net outflow of 11.76 thousand CNY [2]. Financial Data - The latest financial report indicates earnings per share of 0.302 CNY, operating profit of 0.32 billion CNY, and a net profit of 22,894,941.58 CNY [3]. - The sales gross margin stands at 49.824% [3]. Related Industries/Concepts - The stock is associated with sectors such as communication equipment (0.45%), edge computing (0.82%), industrial internet (0.96%), and the Internet of Things (0.55%) [4].

Group 1 - The stock of Xingqiu Graphite (688633) has a comprehensive score of 58.43, indicating a strong performance [1] - The main cost analysis shows the following prices: current main cost at 27.97 yuan, 5-day main cost at 27.65 yuan, 20-day main cost at 26.99 yuan, and 60-day main cost at 27.34 yuan [1] - The stock has not experienced any limit-up or limit-down events in the past year [1] Group 2 - The short-term resistance level is set at 28.01 yuan, while the short-term support level is at 26.89 yuan [2] - The mid-term resistance level is at 26.18 yuan, and the mid-term support level is currently unclear, awaiting direction from main funds [2] - The K-line pattern indicates a bullish signal, suggesting potential upward movement from the bottom, continuation in the middle, and a composite top signal at the peak [2] Group 3 - On July 11, 2025, the net inflow of main funds was 52.59 thousand yuan, accounting for 2% of the total transaction volume [2] - Large orders showed a net inflow of 52.59 thousand yuan, while retail investors experienced a net outflow of 13.53 thousand yuan [2] - Related industry sectors include specialized equipment (0.53%), phosphorus chemical industry (0.15%), new materials (0.39%), and intellectual property (1.00%) [2]

Group 1 - The stock of DeMa Technology (688360) has a comprehensive score of 57.68, indicating a strong performance [1] - The main cost analysis shows the following prices: current main cost at 19.31 yuan, 5-day main cost at 19.09 yuan, 20-day main cost at 18.35 yuan, and 60-day main cost at 17.97 yuan [1][2] - The stock has experienced no limit-up occurrences and one limit-down occurrence in the past year [1] Group 2 - Short-term resistance is at 19.60 yuan, while short-term support is at 18.31 yuan; the mid-term resistance is at 16.85 yuan, and mid-term support is currently unclear [2] - As of July 11, 2025, the net inflow of main funds is 22.96 million yuan, accounting for 10% of the total transaction volume [2] - The financial data indicates earnings per share of 0.17 yuan, operating profit of 0.43 billion yuan, and a sales gross margin of 32.119% [3][2] Group 3 - The stock is associated with various sectors, including General Equipment (0.54%), Digital Twin (0.66%), Lithium Battery (0.11%), and Artificial Intelligence (0.83%) [4]

Group 1 - The stock of Nuotai Bio (688076) has a comprehensive score of 52.17, indicating a strong performance [1] - The main cost analysis shows the following prices: current main cost at 38.88 CNY, 5-day main cost at 38.12 CNY, 20-day main cost at 37.85 CNY, and 60-day main cost at 37.20 CNY [1] - There have been no instances of the stock hitting the upper or lower limits in the past year [1] Group 2 - On July 11, 2025, the net inflow of main funds was 136.09 million CNY, accounting for 16% of the total transaction volume [2] - The stock's earnings per share (EPS) is 0.69 CNY, with an operating profit of 178 million CNY and a net profit of approximately 147.87 million CNY [2][3] - The sales gross margin stands at 70.204% [2][3] Group 3 - The stock is associated with several industry sectors, including medical services (1.48%), CRO (Contract Research Organization) (2.56%), influenza (0.63%), and hepatitis concepts (0.68%) [2][3] - Short-term and mid-term trends are currently unclear, with the market awaiting direction from main funds [2][3]

Group 1 - The stock of Huaxing Yuanchuang (688001) has a comprehensive score of 52.07, indicating a strong performance [1] - The main cost analysis shows that the current main cost is 25.18 yuan, with a 5-day main cost of 24.90 yuan, a 20-day main cost of 24.75 yuan, and a 60-day main cost of 24.64 yuan [1] - In the past year, the stock has experienced 0 limit-up days and 1 limit-down day [1] Group 2 - On July 11, 2025, the stock price broke through the short-term resistance level of 25.01 yuan, suggesting a potential short-term strength [2] - The short-term support level is at 24.62 yuan, while the mid-term resistance and support levels are at 25.51 yuan and 23.86 yuan, respectively [2] - The net inflow of main funds on July 11, 2025, was 3.88 million yuan, accounting for 7% of the total transaction amount [2]

暴拉！完美踏空了吗？ 和讯自选股写手 （原标题：暴拉！完美踏空了吗？） 今日沪指再创新高，仍是银行股狂欢，银行指数涨0.97%，若剔除银行股贡献，沪指或下跌。个股涨跌 比为2943:2279，但上涨股票整体涨幅不大，中位数约0.17%。题材股昨日大涨后今日震荡，与银行股轮 流表现。除银行外，地产股表现不错，稀土、水泥等传统板块也有表现，券商板块涨1.47%，2只涨 停。指数目前问题不大，银行股难连续拉大阳线，震荡期间题材股或表现。操作上，不建议追高银行 股，可在超跌成长题材股等风口。此外，还谈及投资心态、人生感悟，提醒把握时间做有价值之事，靠 自身价值抵御风险。 风险提示：以上内容仅作为作者或者嘉宾的观点，不代表和讯的任何立场，不构成与和讯相关的任何投 资建议。在作出任何投资决定前，投资者应根据自身情况考虑投资产品相关的风险因素，并于需要时咨 询专业投资顾问意见。和讯竭力但不能证实上述内容的真实性、准确性和原创性，对此和讯不做任何保 证和承诺。 本文由 AI 算法生成，仅作参考，不涉投资建议，使用风险自担 股票名称 "英伟达" 板块名称 "银行","地产","券商" 沪指、银行股、题材股 看多看空 内容中提到 ...

Group 1 - A-shares experienced volatility around the 3500-point mark, with significant selling pressure from trapped investors, making it difficult to break through this level [1] - The banking sector's rise is seen as a reflection of reduced market risk appetite, indicating a tug-of-war between bulls and bears [1] - The external environment remains challenging due to tariff issues, yet the pharmaceutical sector showed strong performance, with innovative drugs in both Hong Kong and A-shares rebounding [1] Group 2 - June CPI increased by 0.1% year-on-year, while PPI decreased by 3.6% year-on-year, indicating mixed economic signals [1] - Companies such as Muyuan Foods and Northern Rare Earth have released earnings forecasts, showing a mix of positive and negative outlooks [1] - Foster's performance is expected to decline due to intense competition in the photovoltaic sector, while Ganli Pharmaceutical and Hongta Securities anticipate earnings growth [1]